0001415889-25-009201.txt : 20250328 0001415889-25-009201.hdr.sgml : 20250328 20250328175402 ACCESSION NUMBER: 0001415889-25-009201 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20250327 FILED AS OF DATE: 20250328 DATE AS OF CHANGE: 20250328 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Higgins Jack CENTRAL INDEX KEY: 0001993684 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39580 FILM NUMBER: 25788113 MAIL ADDRESS: STREET 1: C/O MORPHIMMUNE INC. STREET 2: 101 FOUNDRY DRIVE, SUITE 1200 CITY: WEST LAFAYETTE STATE: IN ZIP: 47906 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Immunome Inc. CENTRAL INDEX KEY: 0001472012 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 770694340 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 18702 N. CREEK PARKWAY STREET 2: SUITE 100 CITY: BOTHELL STATE: WA ZIP: 98011 BUSINESS PHONE: 610-321-3700 MAIL ADDRESS: STREET 1: 18702 N. CREEK PARKWAY STREET 2: SUITE 100 CITY: BOTHELL STATE: WA ZIP: 98011 4 1 form4-03282025_090359.xml X0508 4 2025-03-27 0001472012 Immunome Inc. IMNM 0001993684 Higgins Jack C/O IMMUNOME, INC. 18702 N. CREEK PARKWAY, SUITE 100 BOTHELL WA 98011 false true false false Chief Scientific Officer 0 Common Stock 2025-03-27 4 M 0 5200 1.35 A 18729 D Employee Stock option (right to buy) 1.35 2025-03-27 4 M 0 5200 0 D 2032-06-23 Common Stock 5200 173840 D 25% of the shares vested on May 1, 2023, and the remaining shares shall vest in 36 equal monthly installments thereafter. /s/ Sandra Stoneman, Attorney-in-Fact 2025-03-28